Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebenezer Oloyede

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Schizophrenia Bulletin|October 15, 2021
Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?Graham Blackman, Ebenezer Oloyede, Mark Horowitz, et al.
Acta Psychiatrica Scandinavica|January 27, 2021
An evaluation of the variation and underuse of clozapine in the United KingdomEromona Whiskey, Alex Barnard, Ebenezer Oloyede, et al.
Acta Psychiatrica Scandinavica|October 30, 2023
Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic reviewEbenezer Oloyede, Aikaterini Dima, David Taylor, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 8, 2016
Continuous patient engagement in cardiovascular disease clinical comparative effectiveness researchJoseph Vandigo, Ebenezer Oloyede, Abdalla Aly, et al.
BMC Psychiatry|June 8, 2023
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropeniaEbenezer Oloyede, Danielle Dunnett, David Taylor, et al.
Schizophrenia (Heidelberg, Germany)|April 28, 2023
What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention cliniciansEbenezer Oloyede, Graham Blackman, Bethany Mantell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 26, 2026
Acceptability and accuracy of point-of-care monitoring of lithium levelsMatthew Atkins, Clarisse Lagman, Ebenezer Oloyede, et al.
Therapeutic Advances in Psychopharmacology|July 14, 2022
Vortioxetine as adjunctive therapy in the treatment of schizophreniaSofia Redaelli, Lilla Porffy, Ebenezer Oloyede, et al.
Journal of Psychopharmacology (Oxford, England)|October 27, 2021
Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case seriesDanielle Dunnett, Ebenezer Oloyede, Oluwakemi Oduniyi, et al.
Bjpsych Open|August 4, 2020
Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image studyCecilia Casetta, Fiona Gaughran, Ebenezer Oloyede, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Schizophrenia Bulletin|October 15, 2021
Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation-Is It Feasible to Develop Evidence-Based Guidelines?Graham Blackman, Ebenezer Oloyede, Mark Horowitz, et al.
Acta Psychiatrica Scandinavica|January 27, 2021
An evaluation of the variation and underuse of clozapine in the United KingdomEromona Whiskey, Alex Barnard, Ebenezer Oloyede, et al.
Acta Psychiatrica Scandinavica|October 30, 2023
Clozapine augmentation with long-acting antipsychotic injections: A case series and systematic reviewEbenezer Oloyede, Aikaterini Dima, David Taylor, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 8, 2016
Continuous patient engagement in cardiovascular disease clinical comparative effectiveness researchJoseph Vandigo, Ebenezer Oloyede, Abdalla Aly, et al.
BMC Psychiatry|June 8, 2023
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropeniaEbenezer Oloyede, Danielle Dunnett, David Taylor, et al.
Schizophrenia (Heidelberg, Germany)|April 28, 2023
What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention cliniciansEbenezer Oloyede, Graham Blackman, Bethany Mantell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 26, 2026
Acceptability and accuracy of point-of-care monitoring of lithium levelsMatthew Atkins, Clarisse Lagman, Ebenezer Oloyede, et al.
Therapeutic Advances in Psychopharmacology|July 14, 2022
Vortioxetine as adjunctive therapy in the treatment of schizophreniaSofia Redaelli, Lilla Porffy, Ebenezer Oloyede, et al.
Journal of Psychopharmacology (Oxford, England)|October 27, 2021
Evaluation of the effectiveness and acceptability of the long-acting oral antipsychotic penfluridol: Illustrative case seriesDanielle Dunnett, Ebenezer Oloyede, Oluwakemi Oduniyi, et al.
Bjpsych Open|August 4, 2020
Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image studyCecilia Casetta, Fiona Gaughran, Ebenezer Oloyede, et al.
Pageof 4